(Pictured) NIH researchers have created a 4D brain map in an animal model that reveals the potential early warning signs of ...

In patients with relapsing MS, the transition to cladribine from natalizumab is a safe and effective option that provides sustained disease stability.

A statistical model that takes into account clinical and demographic factors could help guide decisions about treatment in ...

Safety Review Committee Found No Safety Concerns Following Milestone TrialTORONTO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd.

Here's what MS is, what causes it and how you can expect the condition to be treated if it impacts you or someone you love.

A diet rich in fish may help slow down the progression of the incurable, often disabling autoimmune disease of multiple ...

Since 2013, diagnoses of multiple sclerosis (MS) in Finland take less time after symptom onset and treatments follow the ...

In collaborative work, Trethera and the Peter Clark Lab at UCLA have shown that when autoreactive T and B cells divide, they ...

At the booming biotech campus of Pegasus Park in Dallas, up-and-coming biopharmaceutical company GenrAb believes it’s onto ...

Using an animal model of multiple sclerosis (MS), researchers have created a four-dimensional brain map that reveals how lesions similar to those seen in human MS form. These findings provide a window ...

Dr Annalisa Morgan previews discussions on disease-modifying therapies, emerging treatments such as CAR T-cell therapy, and ...